RLF — RELIEF THERAPEUTICS Holding SA Balance Sheet
0.000.00%
- CH₣29.53m
- CH₣16.60m
- CH₣8.42m
- 28
- 26
- 27
- 14
Annual balance sheet for RELIEF THERAPEUTICS Holding SA, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 38.2 | 44.8 | 19.2 | 14.6 | 15.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 1.73 | 2.19 | 1.84 | 2.03 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 46.9 | 55 | 22.6 | 18.3 | 19.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 2.54 | 2.69 | 2.97 | 2.4 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 78 | 252 | 189 | 76.4 | 53.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.69 | 19.7 | 10.7 | 6.91 | 4.98 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11 | 70.1 | 43.4 | 24.2 | 16.6 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 67 | 182 | 145 | 52.2 | 36.7 |
Total Liabilities & Shareholders' Equity | 78 | 252 | 189 | 76.4 | 53.2 |
Total Common Shares Outstanding |